AstraZeneca Says CEO McKillop Will Stay Through 2006 Despite Rumors
This article was originally published in The Pink Sheet Daily
Executive Summary
The British financial press speculates that McKillop could depart to become chairman of the Royal Bank of Scotland, but the bank says its current chairman could stay on for an additional five years. AstraZeneca board and McKillop have reached a new contract that would extend his employment beyond 2005, company says.
You may also be interested in...
AstraZeneca CEO Designate Brennan Will Take Reins From McKillop In 2006
Selection of U.S. head David Brennan to succeed retiring CEO Tom McKillop was the result of a search that focused on internal candidates.
AstraZeneca CEO Designate Brennan Will Take Reins From McKillop In 2006
Selection of U.S. head David Brennan to succeed retiring CEO Tom McKillop was the result of a search that focused on internal candidates.
AstraZeneca Refocuses On Risk Management, Elevates Development Oversight
Former Exec VP-Product Strategy & Licensing John Patterson will assume the board-level position of exec director-development effective Jan. 1. Regulatory affairs overhaul will include a review of ongoing Phase III programs for Galida, Cerovive and Symbicort.